Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEating a larger-than-expected portion on Mounjaro typically brings on an uncomfortable rush of nausea, bloating and upper-stomach discomfort — sometimes vomiting. That reaction is the medicine's mechanism working as intended, not a sign that something has gone wrong. Mounjaro (tirzepatide) slows the rate at which food leaves your stomach, so a meal that would once have passed through in an hour or two now lingers considerably longer. Overshoot your capacity and your digestive system pushes back, hard. These medicines are prescription-only and require clinical assessment before starting; your prescriber will always be the right person to discuss any persistent symptoms with.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people expect tirzepatide to quietly dampen appetite in the background, a gentle nudge away from the biscuit tin. The reality is more physiological than that. Mounjaro activates both GIP and GLP-1 receptors simultaneously, which means it also substantially slows how quickly your stomach empties. A meal that your digestive system once cleared in an hour may now take two or three times as long. When you eat beyond your new, reduced capacity, the food has nowhere to go quickly, and your body responds with bloating, reflux, nausea or vomiting. It is not a punishment built into the medicine; it is a direct consequence of a gastric-emptying system that has been genuinely altered by treatment. The full guide to Mounjaro covers how this dual-receptor mechanism works in more detail, but the practical upshot is simple: the margin for overeating shrinks considerably on tirzepatide, often more than people expect.
Understanding this changes the goal. The aim is not to power through the discomfort or assume you will adapt quickly. It is to learn your new threshold early, before a difficult evening meal teaches you the hard way.
Picture a stomach that is draining more slowly than usual. Add a large portion (or even a standard restaurant main) and the pressure builds. Nausea arrives first for most people, often within 20 to 40 minutes. That may be followed by burping, reflux into the chest, or a heavy bloated sensation that lasts several hours. In some cases vomiting follows. Fatigue and a dull headache are also reported, partly from the effort of digestion and partly from mild dehydration if vomiting has occurred. The NHS's patient guidance on tirzepatide confirms that nausea, vomiting, diarrhoea and stomach pain are among the most common effects across the treatment, and overeating is one of the clearest triggers. Our dedicated page on what happens if you over eat on Mounjaro explains why these symptoms cluster in the early weeks of each new dose and sets out the detail behind them. These symptoms do ease as your body adjusts, but repeatedly overeating delays that adjustment and can make the side-effect window feel much longer than it needs to be.
If you are finding these reactions frequent or severe, it is also worth reading about what happens if you don't eat on Mounjaro, because skipping meals entirely carries its own risks that are just as important to understand. It is also worth reading about what eating too little on Mounjaro does, because the two patterns are often connected: a difficult meal leads to restriction the next day, then hunger peaks, then another large portion, and the cycle continues.
Before you serve your plate, try halving what you would previously have considered a normal portion, then wait ten minutes after finishing before deciding whether to eat more. That pause accounts for the lag in satiety signals that gastric slowing creates. If you feel comfortable after ten minutes, a small top-up is reasonable. Most people find they do not want one. This is not about calorie counting; it is about giving your stomach the time to send its fullness signal through a system that now delivers that signal at a different pace. Eating slowly, setting cutlery down between bites and avoiding high-fat or heavily processed meals also reduce the load on a stomach that is emptying more slowly than it used to. The practical guide to the Mounjaro injection touches on lifestyle adjustments that prescribers commonly recommend alongside the medicine.
High-fat meals are worth particular attention. Fat slows gastric emptying even without medication; pair it with tirzepatide's effect and the combined slowdown can be severe. Rich or fried food is one of the most reliably reported triggers for prolonged nausea among people on this treatment. When you are looking at how to adjust your eating patterns during treatment, our weight-loss treatment overview can provide useful context on what clinical support typically looks like.
Most overeating reactions on Mounjaro are miserable but short-lived. There are a handful of symptoms that warrant medical attention rather than waiting it out. Severe, persistent stomach pain that radiates into your back (rather than the generalised bloating described above) should be assessed by a clinician promptly. In January 2026 the MHRA issued a Drug Safety Update specifically for GLP-1 medicines, highlighting acute pancreatitis as an infrequent but serious risk that can present with exactly this kind of radiating pain, with or without vomiting. Persistent vomiting that stops you keeping fluids down is also a reason to seek help; dehydration affects kidney function, and tirzepatide's prescribing information flags this risk specifically. Suspected side effects can be reported via the MHRA Yellow Card scheme by you or by your prescriber.
If you are concerned about whether overeating on tirzepatide could signal a dose issue or a clinical concern, it is worth understanding what happens if you take too much Mounjaro and how that affects your treatment plan. And if you are experiencing reactions you are not sure how to manage, speaking with our clinical team directly is the right move. To explore whether treatment through a clinician-led service is appropriate for you, you can speak to our prescribers through a free consultation, there is no obligation, and every response is read by a GPhC-registered Independent Prescriber the same day it is submitted.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.